GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 711 filers reported holding GLAXOSMITHKLINE PLC in Q3 2015. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $5,000 | +400.0% | 109 | +395.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 22 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | -83.3% | 22 | -85.3% | 0.00% | -100.0% |
| Q3 2018 | $6,000 | +500.0% | 150 | +581.8% | 0.00% | – |
| Q2 2018 | $1,000 | -85.7% | 22 | -87.3% | 0.00% | -100.0% |
| Q1 2018 | $7,000 | -30.0% | 173 | -40.3% | 0.00% | -33.3% |
| Q4 2017 | $10,000 | +900.0% | 290 | +1218.2% | 0.00% | – |
| Q3 2017 | $1,000 | -99.9% | 22 | -99.9% | 0.00% | -100.0% |
| Q2 2015 | $1,083,000 | -12.2% | 25,935 | -2.9% | 1.04% | +1.3% |
| Q1 2015 | $1,233,000 | -8.0% | 26,718 | -14.8% | 1.02% | +21.5% |
| Q4 2014 | $1,340,000 | -6.2% | 31,343 | +0.9% | 0.84% | -10.3% |
| Q3 2014 | $1,428,000 | +41.4% | 31,054 | +64.4% | 0.94% | +34.3% |
| Q2 2014 | $1,010,000 | +9.3% | 18,890 | +9.2% | 0.70% | +7.9% |
| Q1 2014 | $924,000 | – | 17,293 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |